| Literature DB >> 25599018 |
Christopher P Jackman1, Ilya Y Shadrin1, Aaron L Carlson1, Nenad Bursac1.
Abstract
Engineered cardiac tissues hold great promise for use in drug and toxicology screening, in vitro studies of human physiology and disease, and as transplantable tissue grafts for myocardial repair. In this review, we discuss recent progress in cell-based therapy and functional tissue engineering using pluripotent stem cell-derived cardiomyocytes and we describe methods for delivery of cells into the injured heart. While significant hurdles remain, notable advances have been made in the methods to derive large numbers of pure human cardiomyocytes, mature their phenotype, and produce and implant functional cardiac tissues, bringing the field a step closer to widespread in vitro and in vivo applications.Entities:
Year: 2015 PMID: 25599018 PMCID: PMC4293542 DOI: 10.1016/j.coche.2014.11.004
Source DB: PubMed Journal: Curr Opin Chem Eng ISSN: 2211-3398 Impact factor: 5.163